Yonghua Zhang

Yonghua Zhang

Auto-generated profile, based on publicly available information

Yonghua Zhang

Department of Oncology, Zhangjiagang Traditional Chinese Medicine Hospital Affiliated to Nanjing University of Chinese Medicine, Zhangjiagang 215600, Jiangsu Province, China

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 October 2021 in Frontiers in Cell and Developmental Biology
Verified
Journal Article
Open access
YLYuan-Jie Liu
Yuan-Jie Liu
SZShu-Hong Zeng
Shu-Hong Zeng
YHYi-Dou Hu
Yi-Dou Hu
YZYong-Hua Zhang
Yong-Hua Zhang
JLJiepin Li
Jiepin Li
Graphical (A) Study Flow chart, (B) Diagram depicting the regulation mechanism of NREP in the tumorigenesis of gastric cancer.

25 January 2021 in International Journal Of Clinical Practice
Verified
Journal Article
Closed access
PDF file
YLYulin Liang
Yulin Liang
FWFang Wang
Fang Wang
GCGuoru Chen
Guoru Chen
WLWei Lu
Wei Lu
YZYonghua Zhang
Yonghua Zhang

10 March 2022 in Proceedings of Anticancer Research
Verified
Journal Article
Open access
PDF file
YQYi Qin
Yi Qin
MTMinxian Tao
Minxian Tao
LSLili Song
Lili Song
WQWeihua Qian
Weihua Qian
HGHaijian Gao
Haijian Gao
YPYingying Pan
Yingying Pan
Objective: To establish a new genomic signature for the prognosis of survival in relation to the tumor microenvironment in esophageal adenocarcinoma. Methods: Data from The Cancer Genome Atlas (TCGA) were applied, and the stromal and immune scores of patients with esophageal adenocarcinoma (EAC) were generated through the ESTIMATE algorithm. Differentially expressed genes were obtained, and genes concerning immune prognosis were identified on the basis of these scores. Functional analysis showed that these genes were primarily involved in immunobiological processes. Additionally, CIBERSORT was used to analyze 22 subgroups of tumor-infiltrating immune cells in the tumor microenvironment. Results: The results of the genomic assessment shown on the Kaplan-Meier curve revealed that EAC patients with high-risk scores have the worst survival. The risk score is valid as an independent prognostic factor for the overall survival in EAC patients. The tumor microenvironment was systematically analyzed, and the immune-related prognostic biomarkers of EAC have been proposed. Conclusion: The expression of tumor-infiltrating immune cells and immune-related genes in EAC have been identified. Some previously overlooked genes may be used as additional biomarkers for EAC in the future.